Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Aftertreated polymer
Patent
1998-04-14
1999-10-12
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Aftertreated polymer
424649, 514 6, 525 541, 530330, 530345, A61K 3178, A61K 3324, C07K 5103, C08F 842
Patent
active
059651180
ABSTRACT:
A polymer-platinum compound for use in tumor treatment is described. The compound is composed of a polymer backbone having platinum-containing side chains spaced along the polymer backbone. The side chains are composed of an oligopeptide attached at one end to the backbone and at the other end to the platinum compound.
REFERENCES:
patent: 4062831 (1977-12-01), Kopecek et al.
patent: 4097470 (1978-06-01), Drobnik et al.
patent: 4931553 (1990-06-01), Gill et al.
patent: 5037883 (1991-08-01), Kopecek et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5420105 (1995-05-01), Gustavson et al.
patent: 5473055 (1995-12-01), Mongelli et al.
patent: 5547667 (1996-08-01), Angelucci et al.
patent: 5569720 (1996-10-01), Mongelli et al.
Bogdanov, A.A., et al., "An Adduct of cis-Diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-Succinate: Synthesis and Cytotoxic Properties," Bioconjugate Chem. 7: 144-149 (1996).
Duncan, R., et al., "The role of polymer conjugates in the diagnosis and treatment of cancer," S.T.P. Pharma Sciences 6(4):237-263 (1996).
Duncan, Ruth, "Drug-polymer conjugates: potential for improved chemotherapy," Anti-Cancer Drugs #:175-210 (1992).
Duncan, R., et al., "Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro," Br. J. Cancer 55:165-174 (1987).
Fiebig, H.H., et al., "GB-21, a novel platinum polymer with antitumor activity in human renal and mammary xenografts," Proceedings of the American Association for Cancer Research 37:297 Abstract No. 2021 (1996).
Filipova-Voprsalova, Marie, et al., "Biodistribution of trans-1,2-diaminocyclohexane-trimellito-platinum(II) attached to macromolecular carriers I. Poly (hydroxyethyl-D,L-asparagine) carrier," Journal of Controlled Release 17: 89-98 (1991).
Fujii, K., et al., "Control of Pharmacokinetics and Nephrotoxicity of cis-DDP by Alginate," Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 23: 639-640 (1996).
Han, Man Jung, et al., "Synthesis and Antitumor Activity of Polyanion-Pt-Complexes Containing Alicyclic Amines as Ligands," Journal of Bioactive and Compatible Polymers 9: 142-151 (1994).
Johnsson, A., et al., "A topographic study on the distribution of cisplatin in xenografted tumors on nude mice," Anti-Cancer Drugs 7: 70-77 (1996).
Neuse, E.W., et al., "Carrier Polymers for Cisplatin-type Anticancer Drug Models," Polymers for Advanced Technologies vol. 7, John Wiley & Sons, Ltd, pp. 867-872, 1996.
Neuse, E.W., et al., "cis-Diaminedichloroplatinum(II) Complexes Reversibly Bound to Water-Soluble Polyaspartamide Carriers for Chemotherapeutic Applications. II: Platinum Coordination to Ethylenediamine Ligands Attached to Poly(ethylene oxide)-Grafted Carrier Polymers," Journal of Inorganic and Organometallic Polymers 5(3): 195-207 (1995).
Schechter, B., et al., "Soluble Polymers as Carriers of Cis-Platinum," Journal of Controlled Release 10: 75-87 (1989).
Seymour, L.W., et al., "Effect of molecular weight (M.sub.w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats," Journal of Biomedical Materials Research 21: 1341-1358 (1987).
Sohn, Youn Soo, et al., "Synthesis and antitumor activity of novel polysphosphazene-(diamine) platinum (II)," Int. J. Pharm 153:79-91 (1997).
Sohn, Youn Soo, et al., "A novel polymeric platinum (II) anticancer agent KI 30606. Preclinic studies of a water-soluble polyphosphazene-Pt (DACH) conjugate," Abstract No. 118, Conference Proceedings (Not dated).
Neuse, E.W., et al., "cis-Diaminedichloroplatinum(II) Complexes Reversibly Bound to Water-Soluble Polyasparatamide Carriers for Chemotherapeutic Applications. I. Platinum Coordination to Preformed Carrier-Attached Ethylenediamine Ligands," J. Inorg. Organomet. Polym. 1(2): 147-165 (1991) .
Buckley Robert G.
Duncan Ruth
Evagorou Evagoras G.
Gianasi Elisabetta
Access Pharmaceuticals Inc.
Mohr Judy M.
Russel Jeffrey E.
LandOfFree
Polymer-platinum compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer-platinum compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer-platinum compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-649328